Julian Adams's Net Worth
-$280 Thousand
Who is Julian Adams?
Julian Adams does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Gamida Cell Ltd., PIERIS PHARMACEUTICALS, INC., INFINITY PHARMACEUTICALS, INC., Elicio Therapeutics, Inc., Neon Therapeutics, Inc., and MILLENNIUM PHARMACEUTICALS INC.
SEC CIK
Julian Adams's CIK is 0001230486
Past Insider Trading and Trends
2003 was Julian Adams's most active year for acquiring shares with 5 total transactions. Julian Adams's most active month to acquire stocks was the month of December. 2003 was Julian Adams's most active year for disposing of shares, totalling 5 transactions. Julian Adams's most active month to dispose stocks was the month of July. 2008 saw Julian Adams paying a total of $320,583.48 for 247,413 shares, this is the most they've acquired in one year. In 2003 Julian Adams cashed out on 15,682 shares for a total of $102,403.46, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Gamida Cell Ltd. (GMDA) No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +89.39% | 200K |
—
|
—
| 423.75K |
Jan 31
| |||
Form 4/A
| +14.48% | 28.3K |
—
|
—
| 223.75K |
Oct 19
| |||
Form 4
| +14.48% | 28.3K |
—
|
—
| 223.75K |
Feb 8
| |||
Form 4
| +1.03% | 2K |
—
|
—
| 195.45K |
Nov 18
| |||
Form 4
| +154.04% | 117.3K |
—
|
—
| 193.45K |
Jul 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PIERIS PHARMACEUTICALS, INC. (PIRS) Snapshot price: $15
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
INFINITY PHARMACEUTICALS, INC. (INFIQ) Snapshot price: $0.000001
President R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 59.15K |
—
|
—
| 59.15K |
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 4
| |||
Form 4
| +109.47% | 137.41K |
$2.33 | $320,583.48 | 262.94K |
Oct 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
∞
| 125.53K |
—
|
—
| 125.53K |
Sep 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Elicio Therapeutics, Inc. (ELTX) Snapshot price: $3.96
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Neon Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |